Bio-Works Technologies
2.87 SEK
-1.37 %
Less than 1K followers
BIOWKS
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Bio-Works Technologies
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.8 | 2.7 | 25.5 | 9.0 | 13.2 | 16.6 | 23.7 | 62.5 |
| EBITDA | -4.9 | -13.7 | -37.5 | -7.7 | -7.5 | -1.1 | -0.8 | -17.0 |
| EBIT | -5.1 | -13.8 | -38.0 | -7.8 | -7.6 | -1.2 | -0.9 | -17.5 |
| EBIT-% | -51.7 % | -519.6 % | -149.2 % | -87.1 % | -57.6 % | -7.4 % | -3.8 % | -28.0 % |
| Profit before taxes | -5.2 | -13.2 | -37.3 | -8.0 | -7.3 | -1.4 | -0.6 | -17.2 |
| Net income | -5.3 | -13.2 | -37.4 | -8.0 | -7.3 | -1.4 | 1.4 | -15.3 |